- Raised $370k funding round led by eHealth Ventures, Feb 2023
- Raised $1.1M funding round led by eHealth Ventures, Jan 2022
- Raised $850k funding round, Oct 2019
About
Ophthalmic Sciences has developed the IOPerfect, a contact-free, image processing-based intraocular pressure (IOP) measurement device designed for in-home telemedicine. Using a VR-like headset, the mobile product uses artificial intelligence algorithms to analyze captured video imaging and provide fast, reliable, user-friendly measurement of IOP, a key biomarker for monitoring and treating glaucoma.
Patients can easily and safely wear the smart headset to monitor their IOP at home anytime. Controlled air pressure is released over the patient's eyes, and a micro-video camera captures the difference in response to pressure on the internal versus the external blood vessels. An AI algorithm then analyzes the processed video to calculate the patient's IOP. The results are immediately delivered to a cloud-based app for telediagnosis by clinicians.
The company's tonometer solution enables highly accurate asynchronous remote monitoring, helping ophthalmologists and optometrists save time while improving patient outcomes and reducing costs for clinics, hospitals, and telehealth providers.
Ophthalmic Sciences is a portfolio company of eHealth Ventures.
Funding history · 3 rounds · $2.3M total
Q&A
- What is the primary product developed by Ophthalmic Sciences?
- Ophthalmic Sciences developed the IOPerfect, a contact-free, image processing-based intraocular pressure (IOP) measurement device for in-home telemedicine.
- What is the current status of Ophthalmic Sciences?
- Ophthalmic Sciences is currently inactive, having ceased to operate in January 2025.
- How many employees does Ophthalmic Sciences have?
- Ophthalmic Sciences has 1-10 employees.
- What is the total amount of funding raised by Ophthalmic Sciences?
- Ophthalmic Sciences has raised a total of $2,320,000.
- When was the last funding round for Ophthalmic Sciences and who were the lead investors?
- The last funding round for Ophthalmic Sciences occurred in February 2023, with eHealth Ventures as the lead investor.
- What technologies are utilized in Ophthalmic Sciences' product?
- Ophthalmic Sciences' product utilizes Virtual Reality, Artificial Intelligence, Cloud, and Simulation & Imaging technologies.
- What is the main purpose of the IOPerfect device?
- The IOPerfect device is designed for fast, reliable, user-friendly measurement of Intraocular Pressure (IOP), a key biomarker for monitoring and treating glaucoma, through a VR-like headset and AI algorithms.
- Who are the target customers for Ophthalmic Sciences' solutions?
- Ophthalmic Sciences targets customers in Healthcare & Life Sciences, specifically healthcare providers and patients.
Sectors & technology
Highlights
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| linkedin.com/company/67906741 | |
| YouTube | youtube.com/@ophthalmicsciences361 |
Identifiers & details
| Founded | 2019-8 |
|---|---|
| Employees (exact) | 3 |
| Status reason | Non Active, Jan 2025 ceased to operate |